7TZU | pdb_00007tzu

Crystal structure of the E. coli thiM riboswitch bound to 1-(4-(piperazin-1-yl)pyridin-3-yl)-N-(quinoxalin-6-ylmethyl)methanamine (linked compound 38)

  • Classification: RNA
  • Organism(s): Escherichia coli
  • Mutation(s): No 

  • Deposited: 2022-02-16 Released: 2022-05-25 
  • Deposition Author(s): Nuthanakanti, A., Serganov, A.
  • Funding Organization(s): National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.87 Å
  • R-Value Free: 
    0.270 (Depositor), 0.272 (DCC) 
  • R-Value Work: 
    0.229 (Depositor), 0.231 (DCC) 
  • R-Value Observed: 
    0.234 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7TZU

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

SHAPE-enabled fragment-based ligand discovery for RNA.

Zeller, M.J.Favorov, O.Li, K.Nuthanakanti, A.Hussein, D.Michaud, A.Lafontaine, D.A.Busan, S.Serganov, A.Aube, J.Weeks, K.M.

(2022) Proc Natl Acad Sci U S A 119: e2122660119-e2122660119

  • DOI: https://doi.org/10.1073/pnas.2122660119
  • Primary Citation Related Structures: 
    7TZR, 7TZS, 7TZT, 7TZU

  • PubMed Abstract: 

    The transcriptome represents an attractive but underused set of targets for small-molecule ligands. Here, we devise a technology that leverages fragment-based screening and SHAPE-MaP RNA structure probing to discover small-molecule fragments that bind an RNA structure of interest. We identified fragments and cooperatively binding fragment pairs that bind to the thiamine pyrophosphate (TPP) riboswitch with millimolar to micromolar affinities. We then used structure-activity relationship information to efficiently design a linked-fragment ligand, with no resemblance to the native ligand, with high ligand efficiency and druglikeness, that binds to the TPP thiM riboswitch with high nanomolar affinity and that modulates RNA conformation during cotranscriptional folding. Principles from this work are broadly applicable, leveraging cooperativity and multisite binding, for developing high-quality ligands for diverse RNA targets.


  • Organizational Affiliation
    • Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.

Macromolecule Content 

  • Total Structure Weight: 27.4 kDa 
  • Atom Count: 1,688 
  • Modeled Residue Count: 79 
  • Deposited Residue Count: 83 
  • Unique nucleic acid chains: 1

Macromolecules

Find similar nucleic acids by:  (by identity cutoff) 
Entity ID: 1
MoleculeChains LengthOrganismImage
RNA (79-MER)83Escherichia coli
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
KWL
(Subject of Investigation/LOI)

Query on KWL



Download:Ideal Coordinates CCD File
B [auth A]1-[4-(piperazin-1-yl)pyridin-3-yl]-N-[(quinoxalin-6-yl)methyl]methanamine
C19 H22 N6
XFJFERUVHIMWDN-UHFFFAOYSA-N
MN

Query on MN



Download:Ideal Coordinates CCD File
E [auth A],
F [auth A],
G [auth A],
H [auth A]
MANGANESE (II) ION
Mn
WAEMQWOKJMHJLA-UHFFFAOYSA-N
MG

Query on MG



Download:Ideal Coordinates CCD File
C [auth A],
D [auth A]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.87 Å
  • R-Value Free:  0.270 (Depositor), 0.272 (DCC) 
  • R-Value Work:  0.229 (Depositor), 0.231 (DCC) 
  • R-Value Observed: 0.234 (Depositor) 
Space Group: P 32 1 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 61.702α = 90
b = 61.702β = 90
c = 102.789γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-2000data scaling
HKL-2000data reduction
PHASERphasing
Cootmodel building

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR01GM112940

Revision History  (Full details and data files)

  • Version 1.0: 2022-05-25
    Type: Initial release
  • Version 1.1: 2023-10-18
    Changes: Data collection, Refinement description